These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 29933439)

  • 1. Understanding and Communicating Measures of Treatment Effect on Survival: Can We Do Better?
    Saad ED; Zalcberg JR; Péron J; Coart E; Burzykowski T; Buyse M
    J Natl Cancer Inst; 2018 Mar; 110(3):232-240. PubMed ID: 29933439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.
    Higashida RT; Furlan AJ; Roberts H; Tomsick T; Connors B; Barr J; Dillon W; Warach S; Broderick J; Tilley B; Sacks D; ;
    Stroke; 2003 Aug; 34(8):e109-37. PubMed ID: 12869717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Net Chance of a Longer Survival as a Patient-Oriented Measure of Treatment Benefit in Randomized Clinical Trials.
    Péron J; Roy P; Ozenne B; Roche L; Buyse M
    JAMA Oncol; 2016 Jul; 2(7):901-5. PubMed ID: 27124210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Measures of survival benefit in cancer drug development and their limitations.
    Etzioni R; Gulati R; Lin DW
    Urol Oncol; 2015 Mar; 33(3):122-7. PubMed ID: 25813143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Guidelines for the conduct of clinical trials for spinal cord injury (SCI) as developed by the ICCP panel: clinical trial outcome measures.
    Steeves JD; Lammertse D; Curt A; Fawcett JW; Tuszynski MH; Ditunno JF; Ellaway PH; Fehlings MG; Guest JD; Kleitman N; Bartlett PF; Blight AR; Dietz V; Dobkin BH; Grossman R; Short D; Nakamura M; Coleman WP; Gaviria M; Privat A;
    Spinal Cord; 2007 Mar; 45(3):206-21. PubMed ID: 17179972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Review of methodological issues of clinical trials in multiple sclerosis.
    Montalban X
    J Neurol Sci; 2011 Dec; 311 Suppl 1():S35-42. PubMed ID: 22206765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endpoints in cancer clinical trials.
    Fiteni F; Westeel V; Pivot X; Borg C; Vernerey D; Bonnetain F
    J Visc Surg; 2014 Feb; 151(1):17-22. PubMed ID: 24440056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The project data sphere initiative: accelerating cancer research by sharing data.
    Green AK; Reeder-Hayes KE; Corty RW; Basch E; Milowsky MI; Dusetzina SB; Bennett AV; Wood WA
    Oncologist; 2015 May; 20(5):464-e20. PubMed ID: 25876994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcome measures in multiple sclerosis clinical trials.
    Andersson PB; Goodkin DE
    Baillieres Clin Neurol; 1997 Oct; 6(3):409-28. PubMed ID: 10101581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. End points and trial design in geriatric oncology research: a joint European organisation for research and treatment of cancer--Alliance for Clinical Trials in Oncology--International Society Of Geriatric Oncology position article.
    Wildiers H; Mauer M; Pallis A; Hurria A; Mohile SG; Luciani A; Curigliano G; Extermann M; Lichtman SM; Ballman K; Cohen HJ; Muss H; Wedding U
    J Clin Oncol; 2013 Oct; 31(29):3711-8. PubMed ID: 24019549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Roaming through methodology. XII. Pragmatic and pathophysiologic trials: a question of goal formulation].
    Algra A; van der Graaf Y
    Ned Tijdschr Geneeskd; 1999 Mar; 143(10):514-7. PubMed ID: 10321260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survival end point reporting in randomized cancer clinical trials: a review of major journals.
    Mathoulin-Pelissier S; Gourgou-Bourgade S; Bonnetain F; Kramar A
    J Clin Oncol; 2008 Aug; 26(22):3721-6. PubMed ID: 18669458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation of single arm versus randomised phase 2 oncology trial characteristics with phase 3 outcome.
    Monzon JG; Hay AE; McDonald GT; Pater JL; Meyer RM; Chen E; Chen BE; Dancey JE
    Eur J Cancer; 2015 Nov; 51(17):2501-7. PubMed ID: 26338195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How a well-grounded minimal important difference can enhance transparency of labelling claims and improve interpretation of a patient reported outcome measure.
    Brozek JL; Guyatt GH; Schünemann HJ
    Health Qual Life Outcomes; 2006 Sep; 4():69. PubMed ID: 17005037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical benefit in oncology trials: is this a patient-centred or tumour-centred end-point?
    Ohorodnyk P; Eisenhauer EA; Booth CM
    Eur J Cancer; 2009 Sep; 45(13):2249-52. PubMed ID: 19545996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recommendations for incorporating patient-reported outcomes into clinical comparative effectiveness research in adult oncology.
    Basch E; Abernethy AP; Mullins CD; Reeve BB; Smith ML; Coons SJ; Sloan J; Wenzel K; Chauhan C; Eppard W; Frank ES; Lipscomb J; Raymond SA; Spencer M; Tunis S
    J Clin Oncol; 2012 Dec; 30(34):4249-55. PubMed ID: 23071244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ECNP consensus meeting. Bipolar depression. Nice, March 2007.
    Goodwin GM; Anderson I; Arango C; Bowden CL; Henry C; Mitchell PB; Nolen WA; Vieta E; Wittchen HU
    Eur Neuropsychopharmacol; 2008 Jul; 18(7):535-49. PubMed ID: 18501566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patient-reported outcomes as end points and outcome indicators in solid tumours.
    Secord AA; Coleman RL; Havrilesky LJ; Abernethy AP; Samsa GP; Cella D
    Nat Rev Clin Oncol; 2015 Jun; 12(6):358-70. PubMed ID: 25754949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Strength of Association Between Surrogate End Points and Survival in Oncology: A Systematic Review of Trial-Level Meta-analyses.
    Prasad V; Kim C; Burotto M; Vandross A
    JAMA Intern Med; 2015 Aug; 175(8):1389-98. PubMed ID: 26098871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Failing to improve overall survival because post-protocol survival is long: fact, myth, excuse or improper study design?
    Prasad V; Vandross A
    J Cancer Res Clin Oncol; 2014 Apr; 140(4):521-4. PubMed ID: 24474554
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.